Ideas
Healthcare leads; biotech M&A catalyst.
Healthcare and biotech strength was the day's clearest sector move, with small and mid healthcare rallying and Trump drug-pricing uncertainty easing through big-pharma agreements. He flagged the JP Morgan Healthcare Conference and active biotech M&A as reasons to watch the group.
Venezuela supply pushes oil lower.
Venezuela's crude being opened to US-linked buyers, with 30-50 million barrels and indefinite sales, should keep medium-term oil supply high and pressure oil prices lower.
Geopolitical risk supports defense stocks.
Rising geopolitical uncertainty, including Venezuela and Greenland tensions, supports owning defense stocks. Morgan Stanley said defense should be held when geopolitical risk rises, and Trump's pressure on contractors to prioritize production supports the theme.
Memory upcycle favors Micron, SK hynix.
Citi sharply raised DRAM and NAND price forecasts, Morgan Stanley lifted SK hynix's target, and UBS raised Micron's target, arguing the memory upcycle can persist through the year with the strongest pricing in Q1.
Rising lithium prices lift Albemarle.
Albemarle is rallying as lithium prices rise, and the coming robotics cycle is cited as another demand driver for lithium and secondary battery materials.
Gene therapy is 2026 biotech theme.
2026 biotech leadership is shifting from obesity toward gene therapy as clinical data improve and big pharma, including Lilly, increases interest and investment. The JP Morgan Healthcare Conference should help confirm this theme.
Hanmi catalysts underappreciated; obesity/MASH pipeline.
Hanmi Pharmaceutical has the fastest muscle-loss-preventing obesity pipeline and its partnered MSD efinopegdutide MASH data are expected in 2026. The stock has not priced in a positive data outcome, so supply could flow in if results are good.
Obesity stocks less exciting than gene therapy.
Obesity remains a large market but the stock-market excitement is fading relative to gene therapy, so she prefers differentiated mechanisms and gene-therapy exposure over generic obesity names.
OliX benefits from Lilly gene-therapy interest.
OliX Pharmaceuticals is developing a gene-therapy modality similar to the Lilly-backed Korean gene-therapy companies. Although the stock is volatile, it should be watched as Lilly expands its Korean gene-therapy footprint.
ADC theme offers many Korean catalysts.
ADC is a massive research area with multiple Korean participants, including LegoChem Biosciences, InToCell, AimedBio, Epis, and Celltrion. She says investors should keep studying the theme because it can generate repeated catalysts.
CES robotics and autonomy drive Hyundai re-rating.
Hyundai Motor was the hottest CES booth, with Boston Dynamics' Atlas and autonomous-driving demonstrations reinforcing its physical-AI and robotics optionality. The stock's sharp CES move reflects a re-rating narrative.
Doosan showcases AIDC power infrastructure.
Doosan drew strong foreign interest at CES by showing group capabilities across robotics, Bobcat, and Doosan Enerbility's AIDC power infrastructure including fuel cells, gas turbines, and SMRs.
Gemini traffic surge supports Alphabet upside.
Alphabet's generative-AI website traffic share jumped from 5.7% to 21.5% as Gemini gains against ChatGPT, and strong TPU demand has pushed the stock to a new high and the No. 2 market-cap position. A move above $4T could change market sentiment.
Patent expirations fuel pharma M&A cycle.
Patent expirations are forcing large pharma to do M&A, and Lilly's large deal activity is waking up the sector. He expects pharma and biotech M&A support to continue through the year.
Samsung capex expansion lifts equipment makers.
Citi expects Samsung Electronics to raise capex following Micron's expansion, and the three global semiconductor leaders' equipment spending remains a leading indicator. If investors believe in capacity expansion, Korean semiconductor equipment and materials stocks should be bought even while weak.
Global nuclear capacity growth supports sector.
The IEA's forecast for global nuclear capacity to rise sharply supports the nuclear theme, and he told investors holding nuclear names to follow the news positively.
Qualcomm order improves Samsung foundry outlook.
Qualcomm's discussions to use Samsung's advanced foundry process for a next-generation AP, following Tesla, would signal improved yields and competitiveness. If Samsung wins, other big tech could follow.
LNG carrier orders start new shipbuilding cycle.
LNG projects expected by 2029 imply about 110 LNG carriers, and with roughly three-year build times the LNG carrier order cycle should begin this year. Korean shipbuilders are the key beneficiaries.
Dollar strength keeps USD/KRW upward.
Global dollar weakness is not guaranteed despite consensus, US investment flows and Korean capital outflows remain strong, and the authorities cannot easily defend the won forever. He sees 1,430 as the floor and 1,550-1,600 as possible upside.
Weak won can lift KOSPI.
If USD/KRW can rise to 1,600, Korean exporters benefit and KOSPI 5,000 is not unreasonable, drawing an analogy to Japan's weak-yen and strong-equity-market experience.
Samsung earnings support higher target prices.
Samsung's Q4 operating profit of 20T won was in line, with memory likely at 17-18T won and foundry losses narrowing. He sees 2026 operating profit around 120-130T won and says analyst targets near 170,000 won do not need to be cut.
Biotech top sector into JPM conference.
Biotech is the top sector to watch into the JP Morgan Healthcare Conference, with obesity and new-drug policy support and strong individual names such as Alteogen, ABL Bio, and DND Pharmatech near highs.
Korean defense benefits from global rearmament.
Among defense, shipbuilding, and biotech, he ranks biotech first but prefers defense over shipbuilding because defense is in shortage, Korea has speed and cost advantages, and order backlogs are already extending to 2028.
SeAH Besteel is defense/space materials play.
He has repeatedly liked SeAH Besteel as a defense, space, and raw-materials play. After its rally, the right approach is to buy on pullbacks rather than chase.
AI demand lifts Samsung Electro-Mechanics.
Samsung Electro-Mechanics is expensive but its AI-related component and substrate exposure should continue through 2027, target prices are rising, and institutions are unlikely to sell into the trend.
Jusung lacks edge; capped upside.
Jusung Engineering is a neither-here-nor-there semiconductor name with no clear technology edge, capped around 40,000 won, high China exposure, and valuation that does not justify more aggressive upside.
SK hynix is cheap memory leader.
Samsung's miss was not a memory problem. SK hynix's HBM-heavy mix and DRAM pricing should produce solid results, and at around 7x earnings versus Micron's 10x it remains a cheap memory leader with an average target near 800,000 won.
Power shortage favors transformer equipment makers.
He picks power equipment and transformers as the sector with the best expected return from current levels, citing Micron's mega fab, Goldman Sachs' power-shortage forecast through 2030, and unresolved old transformer replacement demand.
KOSDAQ mean-reverts after extreme underperformance.
KOSDAQ has underperformed KOSPI by an extreme 20-year relative margin, which historically precedes mean reversion. He expects KOSDAQ to reach 1,100 but warns large-cap leadership may slow the timing.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
254:22
ESS supply chain enters growth cycle.
ESS is the next key small-cap theme, with top-down conditions improving and the first dedicated Korean ESS ETF launching soon. Component and equipment names should benefit as LFP and ESS capacity expands.
S2W is Korea's Palantir-like data AI.
S2W is a Korea-listed AI data analytics company often called Korea's Palantir because it combines dark-web and blockchain data, supplies Interpol, has 80% SaaS revenue, 30% export share, and has absorbed most lock-up overhang.
Snow Peak apparel drives earnings, dividends.
Gamseong Corporation owns the Snow Peak apparel business, has strong Q4 momentum as department-store consumption improves, is a KOSDAQ 150 constituent with value-up disclosure, and offers improving shareholder returns with a dividend yield heading toward 5%.
InnoSpace is unique listed launch play.
InnoSpace is the only listed Korean private launch-vehicle company, focused on the small-satellite taxi launch niche. Policy support is rising, funding risk is lower after last year's capital raise, and a successful H1 launch could close the valuation gap with Rocket Lab.
Amazon Kuiper spending lifts Intellian antennas.
Intellian Technologies is a satellite-antenna turnaround play as Amazon and other LEO players begin large-scale investment. Q3 profitability and Q4 expectations support 2026 earnings momentum.
LG ESS orders lift Shin Sung.
Shin Sung ST is a key ESS component supplier to LG Energy Solution, providing busbars, module cases, heatsinks, and containers for North America LFP and ESS capacity. Its ESS revenue and 2027 capacity outlook are the main drivers.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
285:53
ST Pharm has positive 2026 outlook.
ST Pharm is one of his two preferred biotech R&D names for 2026, with a positive outlook and prior recommendation history.
Park Ji-hoon
Director, Asset Management Consulting Dept., NH Investment & Securities
285:58
Samsung Biologics order momentum supports upside.
Samsung Biologics should have strong momentum from 2025 order intake of 6-7T won and the start of its sixth plant construction.
Samsung SDI ESS growth lifts Hanjung NCS.
Hanjung NCS is an ESS component supplier to Samsung SDI, with cooling plate and immersion-cooling exposure. Operating profit is projected to grow from about 9B won in 2025 to 16B won in 2026, though he still prefers Shin Sung ST on relative price.
Trump defense budget favors Korea defense/shipbuilding.
Trump's push for a 50% defense-budget increase and a dream military supports Korean defense and shipbuilding, including US naval MRO opportunities. Samsung Heavy's MRO move highlights the shipbuilding angle.
Hyundai re-rating continues on robotics, autonomy.
Hyundai Motor's CES-driven move is not just an event. Its robotics and autonomous-driving investments and partnerships with Nvidia and Google DeepMind are different from global automakers, supporting medium-term re-rating above the prior high.
LigaChem ADC tech transfer expected soon.
LigaChem Biosciences is the ADC leader and a delayed technology-transfer deal may arrive early this year, reviving the equity story after a strong ADC track record.
Oral obesity treatments gain 2026 attention.
She favors obesity and ADC within biotech for 2026, with oral obesity treatments gaining attention. G2G Bio, DND Pharmatech, and Hanmi Pharmaceutical are cited as Korean beneficiaries.
Defense budget lifts space/aerospace value chain.
The defense-budget increase should spill over into space, aerospace, and military communications, benefiting value-chain names such as Hanwha Aerospace and Satrec Initiative.
This 3PRO TV (삼프로TV) video, published January 08, 2026,
features Park Myung-sung, Kim Seon-ah, Ryu Jong-eun, Park Byeong-chang, Kim Joon-song, Kim Jang-yeol, Ha Chang-wan, Myung Min-jun, Baek Jung-ki, Park Ji-hoon, Lee Ji-eun
discussing XLV, WTI, ITA, MU, 000660.KS, ALB, LITHIUM, ARKG, 128940.KS, THNR, 226950.KQ, ADC theme, 005380.KS, 034020.KS, GOOGL, Korean semiconductor equipment/materials, URA, 005930.KS, Korean shipbuilders (LNG carriers), USD/KRW, ^KS11, Korean Biotech/Healthcare Sector, Korean defense sector, 001430.KS, 009150.KS, 036930.KQ, Power equipment/transformers, ^KQ11, ESS (energy storage systems), S2W, 036620.KQ, INNOSPACE, 189300.KQ, 416180.KQ, 237690.KQ, 207940.KS, 107640.KQ, Korean shipbuilding sector, 141080.KQ, 012450.KS, 099320.KQ.
43 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Park Myung-sung,
Kim Seon-ah,
Ryu Jong-eun,
Park Byeong-chang,
Kim Joon-song,
Kim Jang-yeol,
Ha Chang-wan,
Myung Min-jun,
Baek Jung-ki,
Park Ji-hoon,
Lee Ji-eun
· Tickers:
XLV,
WTI,
ITA,
MU,
000660.KS,
ALB,
LITHIUM,
ARKG,
128940.KS,
THNR,
226950.KQ,
ADC theme,
005380.KS,
034020.KS,
GOOGL,
Korean semiconductor equipment/materials,
URA,
005930.KS,
Korean shipbuilders (LNG carriers),
USD/KRW,
^KS11,
Korean Biotech/Healthcare Sector,
Korean defense sector,
001430.KS,
009150.KS,
036930.KQ,
Power equipment/transformers,
^KQ11,
ESS (energy storage systems),
S2W,
036620.KQ,
INNOSPACE,
189300.KQ,
416180.KQ,
237690.KQ,
207940.KS,
107640.KQ,
Korean shipbuilding sector,
141080.KQ,
012450.KS,
099320.KQ
